Established as Kohjin Co., Ltd.
Established as Kohjin Co., Ltd. at Suginami-ku, Tokyo, with the capital of JPY 10,000,000.
Started on manufacture of animal blood/sera and culture media for bacterial test.
Built a factory at Hanakage-cho, Sakado, Saitama and the manufacturing base moved there.
Increased the capital to JPY 20,000,000. Built a new factory at Asabano, Sakado and started the manufacture of tissue culture media.
Obtained permission as “Poisonous and deleterious substances manufacturing permit.”
Renamed to Kohjin Bio Co., Ltd.
Increased the capital to JPY 28,000,000.
Launched on production service of customer-oriented monoclonal and polyclonal antibodies.
Increased the capital to JPY 48,000,000.
Started manufacturing in vitro diagnostic agents.
Obtained Medicine manufacturing permit.
Moved the head office to Asabano.
Increased the capital to JPY 70,000,000.
Increased the capital to JPY 98,000,000.
Obtained cosmetics manufacturing permit.
Acquired ISO 13485.
Launched on development and manufacture of normal human dermal keratinocytes.
Obtained medical equipment manufacturing permit, the third-class medical equipment manufacturing sales permit, and the third-class medical equipment manufacturing sales permit.
Establish Kohjin Japan Medical Biology Technological (Beijing) Co., Ltd as 100% subsidiary company in Beijing China.
Purchase all of En Bio’s outstanding shares and acquire ownership.
Kohjin Bio Co., Ltd. has been awarded Saitama Challenge Business Award from Saitama Industrialists Club.
Increased the capital to JPY 140,000,000.
Established Kohjin Bio Holding(Hong Kong)Limited in HongKong
Established Kohjin Bio Technology (Shanghai) Co., Ltd. in Shanghai, China
Raised capital by 335,000,000 Yen